We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Clinical Trial Death Prompts Investigation by Regulators Worldwide
Clinical Trial Death Prompts Investigation by Regulators Worldwide
Regulators around the world are joining forces as part of an investigation into why a patient died after being treated in a Phase 1 clinical study conducted by Biotrial, a French clinical research organization.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor